CU20140133A7 - COMPOSITIONS AND METHODS OF POLYPEPTIDES-OLIGONUCLEOTIDE CHELATE COMPLEX - Google Patents
COMPOSITIONS AND METHODS OF POLYPEPTIDES-OLIGONUCLEOTIDE CHELATE COMPLEXInfo
- Publication number
- CU20140133A7 CU20140133A7 CU2014000133A CU20140133A CU20140133A7 CU 20140133 A7 CU20140133 A7 CU 20140133A7 CU 2014000133 A CU2014000133 A CU 2014000133A CU 20140133 A CU20140133 A CU 20140133A CU 20140133 A7 CU20140133 A7 CU 20140133A7
- Authority
- CU
- Cuba
- Prior art keywords
- methods
- chelate complex
- compositions
- polypeptides
- oligonucleotide chelate
- Prior art date
Links
- 150000004697 chelate complex Chemical class 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 108091034117 Oligonucleotide Proteins 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se describe una composición farmacéutica que contiene un complejo de quelato de oligonucleótido y al menos un polipéptido o polipéptido pegilado. La presente descripción también describe composiciones farmacéuticas adicionales y métodos para el tratamiento de enfermedades que incluyen infecciones virales.A pharmaceutical composition containing an oligonucleotide chelate complex and at least one pegylated polypeptide or polypeptide is described. The present description also describes additional pharmaceutical compositions and methods for the treatment of diseases that include viral infections.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261695035P | 2012-08-30 | 2012-08-30 | |
| PCT/CA2013/050379 WO2013170386A1 (en) | 2012-05-18 | 2013-05-17 | Oligonucleotide chelate complex-polypeptide compositions and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU20140133A7 true CU20140133A7 (en) | 2015-03-30 |
Family
ID=53365658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU2014000133A CU20140133A7 (en) | 2012-08-30 | 2014-11-18 | COMPOSITIONS AND METHODS OF POLYPEPTIDES-OLIGONUCLEOTIDE CHELATE COMPLEX |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU20140133A7 (en) |
-
2014
- 2014-11-18 CU CU2014000133A patent/CU20140133A7/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO7131387A2 (en) | Compositions and methods of oligonucleotide chelate complex-polypeptides | |
| CL2015000295A1 (en) | Compounds derived from alkylpyrimidine; pharmaceutical composition that includes them; Use for the treatment of viral infections and other diseases. | |
| UY34701A (en) | SOLID FORMS OF A THIOPHOSPHORAMIDATE NUCLEOTIDE PROFIT | |
| MX2019009853A (en) | Combination therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers. | |
| MX369041B (en) | CHEMERICAL PROTEINS TYPE ALKALINE PHOSPHATASE. | |
| MX2016008131A (en) | Bicyclic heterocycle compounds and their uses in therapy. | |
| ECSP12012318A (en) | PIRAZOLIL QUINAZOLINA CINASA INHIBITORS | |
| UA116999C2 (en) | SELECTED HEMAGLUTIN ANTIBODY AND PHARMACEUTICAL COMPOSITION TO BE CONTAINED | |
| MX386935B (en) | PRODRUGS OF FUMARATES AND THEIR USE IN THE TREATMENT OF DIFFERENT DISEASES. | |
| MY165124A (en) | Semifluorinated alkane compositions | |
| CL2013003019A1 (en) | Compounds derived from benzothiazole; pharmaceutical composition that includes them; and its use in the treatment of hiv. | |
| BR112015024411A2 (en) | macrocyclic desaza purinones for the treatment of viral infections | |
| BR112017012406A2 (en) | fixed ratio formulation of insulin glargine / lixisenatide | |
| CL2015000784A1 (en) | Compounds derived from acylaminopyrimidine, interferon inducers; pharmaceutical composition that includes them; its use in the treatment of viral infections, immune disorders, cancer and other diseases. | |
| UY35276A (en) | New compounds that inhibit the activity of Lp-PLA2 | |
| BR112014025041B8 (en) | PHARMACEUTICAL COMPOSITION | |
| DOP2016000253A (en) | NEW COMPOUNDS | |
| IN2014CN00572A (en) | ||
| BR112014013972A2 (en) | hcv inhibitors nssa | |
| CL2016002879A1 (en) | Pharmaceutical compositions for treating infectious diseases | |
| LT2939665T (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HIV INFECTIONS | |
| DOP2016000251A (en) | WNT SIGNALING ROAD INHIBITORS | |
| CL2015003431A1 (en) | Pyridone derivatives for the treatment of viral infections and additional diseases | |
| MX2014009244A (en) | A composition and use thereof in the treatment of anal rhagades. | |
| BR112015002979B8 (en) | Crystalline form and pharmaceutical composition |